Package 50090-6310-0
Brand: chlordiazepoxide hydrochloride and clidinium bromide
Generic: chlordiazepoxide hydrochloride and clidinium bromidePackage Facts
Identity
Package NDC
50090-6310-0
Digits Only
5009063100
Product NDC
50090-6310
Description
30 CAPSULE in 1 BOTTLE (50090-6310-0)
Marketing
Marketing Status
Brand
chlordiazepoxide hydrochloride and clidinium bromide
Generic
chlordiazepoxide hydrochloride and clidinium bromide
Sample Package
No
Linked Drug Pages (0)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "44a52833-81d0-4b4a-8f7b-e863b94af466", "openfda": {"unii": ["MFM6K1XWDK", "91ZQW5JF1Z"], "rxcui": ["889614"], "spl_set_id": ["883efb7c-7ab2-434b-9094-5a620375b6d2"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE (50090-6310-0)", "package_ndc": "50090-6310-0", "marketing_start_date": "20230103"}], "brand_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "product_id": "50090-6310_44a52833-81d0-4b4a-8f7b-e863b94af466", "dosage_form": "CAPSULE", "pharm_class": ["Anticholinergic [EPC]", "Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cholinergic Antagonists [MoA]", "Decreased Parasympathetic Acetylcholine Activity [PE]", "Digestive/GI System Activity Alteration [PE]", "GI Motility Alteration [PE]"], "product_ndc": "50090-6310", "dea_schedule": "CIV", "generic_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "active_ingredients": [{"name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "CLIDINIUM BROMIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA214698", "marketing_category": "ANDA", "marketing_start_date": "20210510", "listing_expiration_date": "20261231"}